Skip to main content

AlerisLife Inc. Announces Annual Meeting Results

AlerisLife Inc. (Nasdaq: ALR) announced the results of its 2022 Annual Meeting of Stockholders which was held today.

Bruce M. Gans, M.D. was re-elected as an Independent Director. The final tabulation of the percentage of stockholders’ votes cast for this Independent Director is as follows:

Independent Director

   

Percentage of Shares Voted For

Bruce M. Gans

   

81.3%

Michael E. Wagner, M.D. was re-elected as Independent Director. The final tabulation of the percentage of stockholders’ votes cast for this Independent Director is as follows:

Independent Director

   

Percentage of Shares Voted For

Michael E. Wagner

   

81.5%

Jennifer B. Clark was re-elected as Managing Director. The final tabulation of the percentage of stockholders’ votes cast for this Managing Director is as follows:

Managing Director

   

Percentage of Shares Voted For

Jennifer B. Clark

   

95.7%

Stockholders voted to approve the Second Amended and Restated 2014 Equity Compensation Plan. The final tabulation of the percentage of stockholders’ votes cast for this proposal is as follows:

Proposal

   

Percentage of Shares Voted For

Approval of executive compensation plan

   

79.7%

Stockholders ratified the appointment of Deloitte & Touche LLP as AlerisLife Inc.’s independent auditors to serve for the 2022 fiscal year. The final tabulation of the percentage of stockholders’ votes cast for this proposal is as follows:

Proposal

   

Percentage of Shares Voted For

Ratification of Independent Auditors

   

99.0%

About AlerisLife (Nasdaq: ALR)

AlerisLife enriches and inspires the lives of its older adult customers across the United States by delivering an exceptional and enhanced resident experience to senior living and active adult residents, while also offering lifestyle services to the younger, choice-based consumer. The company is headquartered in Newton, Massachusetts. For more information, visit www.alerislife.com.

Contacts

Michael Kodesch, Director, Investor Relations

(617) 796-8234

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.